View Item 

Show simple item record

Management of hepatitis C patients by primary care physicians in the USA: results of a national survey

dc.contributor.authorShehab, Thomas M.en_US
dc.contributor.authorSonnad, Seema S.en_US
dc.contributor.authorLok, Anna Suk-Fongen_US
dc.date.accessioned2010-06-01T20:58:44Z
dc.date.available2010-06-01T20:58:44Z
dc.date.issued2001-09en_US
dc.identifier.citationShehab, T. M. ; Sonnad, S. S. ; Lok, A. S. F. (2001). "Management of hepatitis C patients by primary care physicians in the USA: results of a national survey." Journal of Viral Hepatitis 8(5): 377-383. <http://hdl.handle.net/2027.42/74072>en_US
dc.identifier.issn1352-0504en_US
dc.identifier.issn1365-2893en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74072
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=11555196&dopt=citationen_US
dc.format.extent95073 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science Ltden_US
dc.rightsBlackwell Science Ltden_US
dc.subject.otherDiagnosisen_US
dc.subject.otherEpidemiologyen_US
dc.subject.otherInterferonen_US
dc.subject.otherRisk Factorsen_US
dc.subject.otherSurveyen_US
dc.subject.otherTreatmenten_US
dc.titleManagement of hepatitis C patients by primary care physicians in the USA: results of a national surveyen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Gastroenterology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationumDepartment of Surgery, University of Michigan Health System, Ann Arbor, Michigan, USAen_US
dc.identifier.pmid11555196en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74072/1/j.1365-2893.2001.00310.x.pdf
dc.identifier.doi10.1046/j.1365-2893.2001.00310.xen_US
dc.identifier.sourceJournal of Viral Hepatitisen_US
dc.identifier.citedreferenceAlter MJ, Kruszon-Moran D, Nainan OV et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556 – 562.en_US
dc.identifier.citedreferencePowell DW for the Hepatitis C Consensus Development Panel. National Institutes of Health consensus development conference panel statement: management of hepatitis C. Hepatology 1997; 26 (Suppl. 1): 2S – 10S.en_US
dc.identifier.citedreference3 Centers for Disease Control and Prevention. Recommendations for prevention, control of hepatitis C, virus (HCV) infection and HCV-related chronic disease. MMWR 1998; 47 (RR–19): 1 – 39.en_US
dc.identifier.citedreferenceSharara AI, Hunt CM, Hamilton JD. Hepatitis C. Ann Intern Med 1996; 125: 658 – 668.en_US
dc.identifier.citedreferenceShehab TM, Sonnad SS, Jeffries M, Gunaratnum N, Lok ASF. Current practice patterns of primary care physicians in the management of patients with hepatitis C. Hepatology 1999; 30: 794 – 800.en_US
dc.identifier.citedreferenceGrumbach K, Becker SH, Osborn EH, Bindman AB. The challenge of defining and counting generalist physicians: an analysis of Physician Masterfile data. Am J Public Health 1995; 85: 1402 – 1407.en_US
dc.identifier.citedreferenceShea JA, Kletke PR, Wozniak GD, Polsky D, Escarce JJ. Self-reported physician specialties and the primary care content of medical practice: a study of the AMA physician masterfile. Med Care 1999; 37: 333 – 338.en_US
dc.identifier.citedreferenceFendrick AM, Hirth RA, Chernew ME. Differences between generalist and subspecialist physicians regarding Helicobacter pylori and peptic ulcer disease. Am J Gastroenterol 1996; 91: 1544 – 1548.en_US
dc.identifier.citedreferenceJames PA, Cowan TM, Graham RP, Majeroni BA. Family physicians’ attitudes about and use of clinical practice guidelines. J Fam Pract 1997; 45: 341 – 347.en_US
dc.identifier.citedreferenceEverhart JE, Stolar M, Hoofnagle JH. Management of hepatitis C, a national survey of gastroenterologists and hepatologists. Hepatology 1997; 26 (Suppl. 1): 78S – 82S.en_US
dc.identifier.citedreferenceSchulman KA, Berlin JA, Harless W et al. The effect of race and sex on physicians’ recommendations for cardiac catheterization. New Engl J Med 1999; 340; 618 – 626.en_US
dc.identifier.citedreferenceFreeman VG, Rathore SS, Weinfurt KP, Schulman KA, Sulmasy DP. Lying for patients: physician deception of third-party payers. Arch Intern Med 1999; 159: 2263 – 2270.en_US
dc.identifier.citedreferenceGroves RM, Cialdini RB, Couper MP. Understanding the decision to participate in a survey. Public Opin Quart 1992; 56: 475 – 495.en_US
dc.identifier.citedreferenceSteeh C. Trends in nonresponse rates. Public Opin Quart 1981; 45: 40 – 57.en_US
dc.identifier.citedreferenceConry-Cantilena C, VanRaden M, Gibble J et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334: 1691 – 1696.en_US
dc.identifier.citedreferenceInglesby TV, Rai R, Astemborski J et al. A prospective, community-based evaluation of liver enzymes in individuals with hepatitis C after drug use. Hepatology 1999; 29: 590 – 596.en_US
dc.identifier.citedreferenceKenny-Walsh E for the Irish Hepatology Group. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. New Engl J Med 1999; 340: 1228 – 1233.en_US
dc.identifier.citedreference18 U.S. Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network. 1999 Annual Report of the U.S. Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network: Transplant Data: 1989–98. HHS/HRSA/OSP/DOT; UNOS, 1999.en_US
dc.identifier.citedreferenceSmith BC, Gorve J, Guzail MA et al. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 1998; 27: 1695 – 1699.en_US
dc.identifier.citedreferenceKazemi-Shirazi L, Datz C, Maier-Dobersberger T et al. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 1999; 116: 127 – 134.en_US
dc.identifier.citedreferenceKundrotas LW & Clement DJ. Serum alanine aminotransferase (ALT) elevation in asymptomatic US Air Force basic trainee blood donors. Dig Dis Sci 1993; 38: 2145 – 2150.en_US
dc.identifier.citedreferenceMathiesen UL, Franzen LE, Fryden A, Foberg U, Bodemar G. The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients. Scand J Gastroenterol 1999; 34: 85 – 91.en_US
dc.identifier.citedreferenceDavis DA & Taylor-Vaisey A. Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ 1997; 157: 408 – 416.en_US
dc.identifier.citedreferenceDavis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA 1995; 274: 700 – 705.en_US
dc.identifier.citedreferenceLok ASF & Gunaratnum NT. Diagnosis of hepatitis C. Hepatology 1997; 26 (Suppl. 1): 48S – 56S.en_US
dc.identifier.citedreferenceGretch DR. Diagnostic tests for hepatitis C. Hepatology 1997; 26 (Suppl. 1): 43S – 47S.en_US
dc.identifier.citedreferenceMcHutchison JG, Gordon SC, Schiff ER et al. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998; 339: 1485 – 1492.en_US
dc.identifier.citedreferencePoynard T, Marcellin P, Lee SS et al. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998; 352: 1426 – 1432.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1365-2893.2001.00310.x.pdf
Size:
92.84KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.